Starton Therapeutics, Inc. and Healthwell Acquisition Corp. I to Present at the Jefferies Healthcare Conference

Author's Avatar
Jun 06, 2023

Starton Therapeutics, Inc. (“Starton” or “the Company”), a clinical-stage biotechnology company focused on transforming standard-of-care therapies with proprietary continuous delivery technology, and Healthwell Acquisition Corp. I (Nasdaq: HWEL) (“Healthwell”), a special purpose acquisition company, today announced that the leadership of Starton and Healthwell will present at the Jefferies Healthcare Conference on June 8th at 11:00 a.m. ET.